The effect of yoga workout and zinc supplementation on type 2 diabetes

Comparison of the effect of eight weeks of zinc supplementation and yoga exercises on plasma apelin levels and renal function in women with type 2 diabetes

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170510033909N2

Enrollment

110

Registered

2019-02-28

Start date

2018-02-19

Completion date

Unknown

Last updated

2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes. Malnutrition-related diabetes mellitus

Interventions

Intervention 1: First intervention group: Yoga practice, which included 3 sessions a week each session for one hour and 8 weeks. Intervention 2: Second intervention group: taking zinc supplements for

Eligibility

Sex/Gender

Female

Age

30 Years to 50 Years

Inclusion criteria

Inclusion criteria: Physical health No history of bone, cardiovascular, respiratory, liver and brain disease Not using zinc supplementation and yoga practice Lack of history of fracture and surgery No history of participation in regular sports activities Not participating in a specific weight loss program, including diet or physical activity Do not drink alcohol or tobacco

Exclusion criteria

Exclusion criteria: People with certain diseases Participate in the sports program Taking anti-inflammatory drugs

Design outcomes

Primary

Measure	Time frame
Apelin. Timepoint: At the beginning of the study (before the intervention) and after the end of 8 weeks. Method of measurement: Blood test - With the Human Apelin Kit made in China by ELISA.;Blood urea nitrogen. Timepoint: At the beginning of the study (before the intervention) and after the end of 8 weeks. Method of measurement: Blood sampling - with the company Pars Co. in Iran, with glucose oxidase method.;Creatinine. Timepoint: At the beginning of the study (before the intervention) and after the end of 8 weeks. Method of measurement: Blood sampling - with the company Pars Co. in Iran, with glucose oxidase method.	—

Measure

Time frame

Apelin. Timepoint: At the beginning of the study (before the intervention) and after the end of 8 weeks. Method of measurement: Blood test - With the Human Apelin Kit made in China by ELISA.;Blood urea nitrogen. Timepoint: At the beginning of the study (before the intervention) and after the end of 8 weeks. Method of measurement: Blood sampling - with the company Pars Co. in Iran, with glucose oxidase method.;Creatinine. Timepoint: At the beginning of the study (before the intervention) and after the end of 8 weeks. Method of measurement: Blood sampling - with the company Pars Co. in Iran, with glucose oxidase method.

—

Secondary

Measure	Time frame
Fasting Glucose. Timepoint: 24 hours before the intervention and 8 weeks after the intervention. Method of measurement: Blood sampling - with the company Pars Co. in Iran, with glucose oxidase method.;Insulin. Timepoint: 24 hours before the intervention and 8 weeks after the intervention. Method of measurement: Blood Collection - Kate Cobas Made in England by Immunoassay.;Insulin resistance. Timepoint: 24 hours before the intervention and 8 weeks after the intervention. Method of measurement: HOMA-IR formula.	—

Measure

Time frame

Fasting Glucose. Timepoint: 24 hours before the intervention and 8 weeks after the intervention. Method of measurement: Blood sampling - with the company Pars Co. in Iran, with glucose oxidase method.;Insulin. Timepoint: 24 hours before the intervention and 8 weeks after the intervention. Method of measurement: Blood Collection - Kate Cobas Made in England by Immunoassay.;Insulin resistance. Timepoint: 24 hours before the intervention and 8 weeks after the intervention. Method of measurement: HOMA-IR formula.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSamira Pahlavani Nejad

Islamic Azad University

anita.sp10@yahoo.com+98 31 3446 9532

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026